Kaj Metsärinne - UTU Research Portal

Kaj Metsärinne

- Docent,
Internal Medicine (Department of Clinical Medicine)

kajmet@utu.fi

4 of 8

Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy statusResistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study (2020)
- Cardiovascular DiabetologyDiabetes Care
Erika B. Parente, Valma Harjutsalo, Markku Lehto, Carol Forsblom, Niina Sandholm, Per-Henrik Groop; and on behalf of the FinnDiane Study Group
(2020)
Lithovius R, Harjutsalo V, Mutter S, Gordin D, Forsblom C, Groop PH; on behalf of the FinnDiane Study Group
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial2020
- European Journal of Preventive Cardiology
Thomas Vanassche, Peter Verhamme, Sonia S Anand, Olga Shestakovska, Keith AA Fox, Deepak L Bhatt, Alvaro Avezum, Marco Alings, Victor Aboyans, Aldo P Maggioni, Petr Widimsky, Scott D Berkowitz, Salim Yusuf, Stuart J Connolly, John W Eikelboom, Jackie Bosch
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI) (2020)
- Circulation
Bainey KR, Welsh RC, Connolly SJ, Marsden T, Bosch J, Fox KAA, Steg PG, Vinereanu D, Connolly DL, Berkowitz SD, Foody JM, Probstfield JL, Branch KR, Lewis BS, Diaz R, Muehlhofer E, Widimsky P, Yusuf S, Eikelboom JW, Bhatt DL; on behalf of the COMPASS Investigators
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial (2020)
- Circulation
Bhatt DL, Eikelboom JW, Connolly SJ, Steg PG, Anand SS, Verma S, Branch KRH, Probstfield J, Bosch J, Shestakovska O, Szarek M, Maggioni AP, Widimsky P, Avezum A, Diaz R, Lewis BS, Berkowitz SD, Fox KAA, Ryden L, Yusuf S; COMPASS Steering Committee and Investigators
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetesSTONE HF -tutkimuksen viesti lääkäreille: suojaa tyypin 2 diabeetikon sydäntä ja munuaisia (2020)
- DiabetologiaDiabetes ja lääkäri
Drazenka Pongrac Barlovic, Valma Harjutsalo, Niina Sandholm, Carol Forsblom, Per-Henrik Groop; on behalf of the FinnDiane Study Group
The association between bacterial infections and the risk of coronary heart disease in type 1 diabetes (2020)
Metsärinne Kaj, Kantola Ilkka, Niskanen Leo, Pietilä Mikko, Poussa Tuija, Stenman Lotta
The COMPASS Trial Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease (2020)
- Journal of Internal Medicine
Simonsen JR, Järvinen A, Harjutsalo V, Forsblom C, Groop, Lehto M
The Long-Term Incidence of Hospitalization for Ketoacidosis in Adults with Established T1D-A Prospective Cohort Study (2020)
- Circulation
Steffel Jan, Eikelboom John W, Anand Sonia S, Shestakovska Olga, Yusuf Salim, Fox Keith AA
The role of polygenic risk and susceptibility genes in breast cancer over the course of life (2020)
- Journal of Clinical Endocrinology and Metabolism
Thomas Merlin, Harjutsalo Valma, Feodoroff Maija, Forsblom Carol, Gordin Daniel, Groop Per-Henrik; FinnDiane Study Group
(2020)
- Nature Communications
Mars N, Widen E, Kerminen S, Meretoja T, Pirinen M, Parolo PD, Palta P; FinnGen, Havulinna A, Palotie A, Kaprio J, Joensuu H, Daly M, Ripatti S
Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan (2020)
- Nature Medicine
Sakaue S, Kanai M, Karjalainen J, Akiyama M, Kurki M, Matoba N, Takahashi A, Hirata M, Kubo M, Matsuda K, Murakami Y, Daly MJ, Kamatani Y, Okada Y
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials (2020)
- Journal of HypertensionLancet
Mancia Giuseppe, Schumacher Helmut, Böhm Michael, Mann Johannes FE, Redon Josep, Facchetti Rita, Schmieder Roland E, Lonn Eva M, Teo Koon K, Yusuf Salim
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialBiomarker panels associated with progression of renal disease in type 1 diabetes (2019)
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; on behalf of the SONAR Committees and Investigators
Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis (2019)
- Diabetologia
Colombo M, Valo E, McGurnaghan SJ, Sandholm N, Blackbourn LAK, Dalton RN, Dunger D, Groop PH, McKeigue PM, Forsblom C, Colhoun HM; FinnDiane Study Group and the Scottish Diabetes Research Network (SDRN) Type 1 Bioresource Collaboration
Body Mass Index and Mortality in Individuals With Type 1 Diabetes (2019)
- Circulation Journal
John W. Eikelboom, MBBS, Stuart J. Connolly, MD, Jacqueline Bosch, PhD, Olga Shestakovska, MSc, Victor Aboyans, MD, Marco Alings, MD, Sonia S. Anand, MD, Alvaro Avezum, MD, PhD, Scott D. Berkowitz, MD, Deepak L. Bhatt, MD, Nancy Cook-Bruns, MD, Camilo Felix, MD, Keith A.A. Fox, MBChB, Robert G. Hart, MD, Aldo P. Maggioni, MD, Paul Moayyedi, MD, Martin O’Donnell, MB, Lars Rydén, MD, Peter Verhamme, MD, Petr Widimsky, MD, Jun Zhu, MD, and Salim Yusuf, MBBS, COMPASS Research Group
CACNB2 Is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabetes (2019)
- Journal of Clinical Endocrinology and Metabolism
Emma H Dahlström, Niina Sandholm, Carol M Forsblom, Lena M Thorn, Fanny J Jansson, Valma Harjutsalo, Per-Henrik Groop; on behalf of the FinnDiane Study Group
Clinical and MRI Features of Cerebral Small-Vessel Disease in Type 1 Diabetes (2019)
- Diabetes
Nadja Vuori, Niina Sandholm, Anmol Kumar, Kustaa Hietala, Anna Syreeni, Carol Forsblom, Kati Juuti-Uusitalo, Heli Skottman, Minako Imamura, Shiro Maeda, Paula A. Summanen, Markku Lehto,Per-Henrik Groop; on behalf of the FinnDiane Study
2019
- Diabetes Care
Lena M. Thorn, Sara Shams Daniel Gordin, Ron Liebkind, Carol Forsblom, Paula Summanen, Stefanie Hägg-Holmberg, Turgut Tatlisumak, Oili Salonen, Jukka Putaala, Juha Martola, Per-Henrik Groop; on behalf of the FinnDiane Study Group
Dietary carbohydrate intake and cardio-metabolic risk factors in type 1 diabetes (2019)
- Diabetes Research and Clinical Practice
Aila J.Ahola, Carol Forsblom Valma Harjutsalo, Per-HenrikGroo, on behalf of the FinnDiane Study Group